![Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)? Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?](https://www.degruyter.com/document/doi/10.1515/cclm-2020-0727/asset/graphic/j_cclm-2020-0727_fig_001.jpg)
Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?
![Synthetic α‐Helical Peptides as Potential Inhibitors of the ACE2 SARS‐CoV‐2 Interaction - Engelhardt - 2022 - ChemBioChem - Wiley Online Library Synthetic α‐Helical Peptides as Potential Inhibitors of the ACE2 SARS‐CoV‐2 Interaction - Engelhardt - 2022 - ChemBioChem - Wiley Online Library](https://chemistry-europe.onlinelibrary.wiley.com/cms/asset/6d1de8a7-4216-4f1a-bcc3-1775a36e8592/cbic202200372-toc-0001-m.jpg)
Synthetic α‐Helical Peptides as Potential Inhibitors of the ACE2 SARS‐CoV‐2 Interaction - Engelhardt - 2022 - ChemBioChem - Wiley Online Library
![SARS-CoV-2 Omicron Variant: ACE2 Binding, Cryo-EM Structure of Spike Protein -ACE2 Complex and Antibody Evasion | bioRxiv SARS-CoV-2 Omicron Variant: ACE2 Binding, Cryo-EM Structure of Spike Protein -ACE2 Complex and Antibody Evasion | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/12/21/2021.12.19.473380/F3.large.jpg)
SARS-CoV-2 Omicron Variant: ACE2 Binding, Cryo-EM Structure of Spike Protein -ACE2 Complex and Antibody Evasion | bioRxiv
![ACE2 binding causes dissociation of trimeric SARS-CoV-2 spike, may be used to inhibit further infection ACE2 binding causes dissociation of trimeric SARS-CoV-2 spike, may be used to inhibit further infection](https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2020/10/Capssture.jpg)
ACE2 binding causes dissociation of trimeric SARS-CoV-2 spike, may be used to inhibit further infection
![SARS‐CoV‐2 first contact: Spike–ACE2 interactions in COVID‐19 - Nesci - 2021 - Chemical Biology & Drug Design - Wiley Online Library SARS‐CoV‐2 first contact: Spike–ACE2 interactions in COVID‐19 - Nesci - 2021 - Chemical Biology & Drug Design - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/685936dc-18fc-4db7-8ecf-2152c9efba15/cbdd13898-toc-0001-m.png)
SARS‐CoV‐2 first contact: Spike–ACE2 interactions in COVID‐19 - Nesci - 2021 - Chemical Biology & Drug Design - Wiley Online Library
![Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor | Nature Communications Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-020-18319-6/MediaObjects/41467_2020_18319_Fig1_HTML.png)
Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor | Nature Communications
![IJMS | Free Full-Text | Geraniin Inhibits the Entry of SARS-CoV-2 by Blocking the Interaction between Spike Protein RBD and Human ACE2 Receptor IJMS | Free Full-Text | Geraniin Inhibits the Entry of SARS-CoV-2 by Blocking the Interaction between Spike Protein RBD and Human ACE2 Receptor](https://pub.mdpi-res.com/ijms/ijms-22-08604/article_deploy/html/images/ijms-22-08604-g004.png?1628669156)
IJMS | Free Full-Text | Geraniin Inhibits the Entry of SARS-CoV-2 by Blocking the Interaction between Spike Protein RBD and Human ACE2 Receptor
![Frontiers | The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and Therapy Frontiers | The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and Therapy](https://www.frontiersin.org/files/Articles/753721/fcimb-11-753721-HTML/image_m/fcimb-11-753721-g001.jpg)
Frontiers | The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and Therapy
![Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains - ScienceDirect Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1931312820306211-fx1.jpg)
Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains - ScienceDirect
Development and simulation of fully glycosylated molecular models of ACE2-Fc fusion proteins and their interaction with the SARS-CoV-2 spike protein binding domain | PLOS ONE
![IJMS | Free Full-Text | Structural and Computational Studies of the SARS-CoV-2 Spike Protein Binding Mechanisms with Nanobodies: From Structure and Dynamics to Avidity-Driven Nanobody Engineering IJMS | Free Full-Text | Structural and Computational Studies of the SARS-CoV-2 Spike Protein Binding Mechanisms with Nanobodies: From Structure and Dynamics to Avidity-Driven Nanobody Engineering](https://www.mdpi.com/ijms/ijms-23-02928/article_deploy/html/images/ijms-23-02928-g001.png)
IJMS | Free Full-Text | Structural and Computational Studies of the SARS-CoV-2 Spike Protein Binding Mechanisms with Nanobodies: From Structure and Dynamics to Avidity-Driven Nanobody Engineering
![Engaging the spikes: heparan sulfate facilitates SARS-CoV-2 spike protein binding to ACE2 and potentiates viral infection | Signal Transduction and Targeted Therapy Engaging the spikes: heparan sulfate facilitates SARS-CoV-2 spike protein binding to ACE2 and potentiates viral infection | Signal Transduction and Targeted Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41392-021-00470-1/MediaObjects/41392_2021_470_Fig1_HTML.png)
Engaging the spikes: heparan sulfate facilitates SARS-CoV-2 spike protein binding to ACE2 and potentiates viral infection | Signal Transduction and Targeted Therapy
![Computational biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivity - Computational and Structural Biotechnology Journal Computational biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivity - Computational and Structural Biotechnology Journal](https://www.csbj.org/cms/attachment/f1304142-00ea-443a-a5f7-5cd21ed0983d/ga1_lrg.jpg)
Computational biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivity - Computational and Structural Biotechnology Journal
![An Update on Novel Soluble ACE2 Therapeutics to Treat SARS-CoV-2: Insights from a Preclinical Study in: Kidney News Volume 13 Issue 3 (2021) An Update on Novel Soluble ACE2 Therapeutics to Treat SARS-CoV-2: Insights from a Preclinical Study in: Kidney News Volume 13 Issue 3 (2021)](https://www.kidneynews.org/view/journals/kidney-news/13/3/full-18f1.jpg)
An Update on Novel Soluble ACE2 Therapeutics to Treat SARS-CoV-2: Insights from a Preclinical Study in: Kidney News Volume 13 Issue 3 (2021)
![Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D0MD00385A Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D0MD00385A](https://pubs.rsc.org/image/article/2021/MD/d0md00385a/d0md00385a-f1_hi-res.gif)
Targeting the SARS-CoV-2-spike protein: from antibodies to miniproteins and peptides - RSC Medicinal Chemistry (RSC Publishing) DOI:10.1039/D0MD00385A
![Researchers discover potential therapeutic targets on SARS-CoV-2 Spike protein | Penn State University Researchers discover potential therapeutic targets on SARS-CoV-2 Spike protein | Penn State University](https://sc-api.psu.edu/s3/files/styles/4_3_1500w/public/Anand.jpg?h=377cff98&itok=KEZIdVli)
Researchers discover potential therapeutic targets on SARS-CoV-2 Spike protein | Penn State University
![Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS-CoV-2 | In Silico Pharmacology Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS-CoV-2 | In Silico Pharmacology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40203-020-00055-w/MediaObjects/40203_2020_55_Fig1_HTML.png)
Peptide modelling and screening against human ACE2 and spike glycoprotein RBD of SARS-CoV-2 | In Silico Pharmacology
![Global conserved RBD fraction of SARS-CoV-2 S-protein with T500S mutation in silico significantly blocks ACE2 and rejects viral spike | Translational Medicine Communications | Full Text Global conserved RBD fraction of SARS-CoV-2 S-protein with T500S mutation in silico significantly blocks ACE2 and rejects viral spike | Translational Medicine Communications | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs41231-022-00109-5/MediaObjects/41231_2022_109_Fig1_HTML.png)